Singapore markets open in 5 hours 37 minutes

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.16+0.30 (+2.02%)
As of 03:22PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-1,710
-61,286
-215,975
-167,870
-281,584
Depreciation & amortisation
10,654
5,552
2,026
3,344
2,932
Stock-based compensation
66,466
66,421
68,201
63,615
84,422
Change in working capital
-4,399
18,133
37,991
-24,824
11,036
Accounts receivable
-28,786
-36,072
2,171
-16,119
-12,466
Inventory
-45,937
-28,808
2,415
-4,210
-3,320
Accounts payable
1,910
4,797
5,870
-1,617
1,271
Other working capital
23,664
-23,348
-114,035
-126,782
-143,753
Other non-cash items
-
-
-
-
44,280
Net cash provided by operating activities
63,714
16,702
-114,035
-125,660
-136,166
Cash flows from investing activities
Investments in property, plant and equipment
-
-40,050
-
-1,122
-7,587
Purchases of investments
-383,247
-369,985
-363,174
-492,797
-339,908
Sales/maturities of investments
248,738
442,033
436,415
422,817
540,004
Net cash used for investing activities
-174,559
31,998
73,241
-71,102
192,509
Cash flows from financing activities
Common stock issued
24,706
25,129
8,199
18,162
80,996
Net cash used provided by (used for) financing activities
24,706
25,129
8,199
18,162
80,996
Net change in cash
-86,150
73,811
-32,589
-178,593
137,331
Cash at beginning of period
296,665
120,616
153,205
331,798
194,467
Cash at end of period
210,526
194,427
120,616
153,205
331,798
Free cash flow
Operating cash flow
63,714
16,702
-114,035
-125,660
-136,166
Capital expenditure
-
-40,050
-
-1,122
-7,587
Free cash flow
23,664
-23,348
-114,035
-126,782
-143,753